Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Hydromer and Allium closes coating services agreement

Hydromer, a polymer-based research and development company, has enteredinto a two-year coating services agreement with the Israeli-basedAllium Medical, a medical device company that develops and manufacturesstents and catheters.

Defibrillator use on the rise in the European market

In order for smaller companies to enter the burgeoning defibrillatormarket, they should forge alliances with businesses that can help themimprove sales, distribution and market share, according the SanJose-based market research firm Frost & Sullivan.

Aloka introduces ultrasound systems for cardiac and vascular markets

Diagnostic ultrasound provider Aloka has introduced two ultrasoundsystems with platforms for cardiac and vascular imaging, the Alpha 10and Alpha 7.

Johnson & Johnson subsidiary settles lawsuit with Angiotech over stent patent

Angiotech Pharmaceuticals, of Vancouver, British Columbia, has reachedan agreement with Johnson & Johnson subsidiary, Conor Medsystemsof Menlo Park, Calif., to settle all outstanding patent litigation withrespect to Conor's CoStar paclitaxel stent.

Philips ultrasound systems rank first in IMV ServiceTrak survey

Customers have rated Royal Philips Electronics’ medical systemsdivision No. 1 in overall service performance for ultrasound allsystems, comprising radiology/OB-GYN and cardiology instruments in anannual IMV ServiceTrak survey.

Study: Drug-coated stents better than bare metal stents

Sirolimus-eluting stents seem to be clinically better than bare metaland paclitaxel-eluting stents in lowering the heart-attack risk forpatients whose arteries were opened, according to study resultspublished in the September issue of The Lancet. Therefore, thestudy endorses the use of Johnson & Johnson’s Cypher, adrug-coated stent, versus Boston Scientific’s Taxus, a bare metaldevice.

FlowCardia completes enrollment for catheter study

Medical device company FlowCardia has announced the completion ofenrollment into its U.S. peripheral approach to recanalization inoccluded totals study, which includes eight hospitals and 85patients and is designed to assess the safety and efficacy of its lineof Crosser catheters in lower limb chronic total occlusions.

European CT market to crest $1 billion by 2013

The European CT systems market is seeing compound annual growth due tothe increased potential of cardiac imaging applications combined withinnovation in clinical applications as well as an improvement in scanspeeds, according to San Jose, Calif.-based market research firm Frost& Sullivan.

Displaying 1569 - 1576 of 1765

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup